Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
Single-Use Systems Growth Rate Plateauing
Nearly One-Half of Biomanufacturers Are Using Disposable Bioreactors, but Adoption Is Slowing
- Single-use bioreactors are making good progress at the commercial scale, with 43.3% of biomanufacturers using them, versus 68.3% at the scale-up/clinical production stage. In this year’s 8th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, we examined the penetration of disposables across all stages of manufacture, as ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.